Pseudohypoglycemia is an event when a person experiences typical symptoms of hypoglycemia but with a measured plasma glucose concentration above 70 mg/dL (>3.9 mmol/L).[1, 2] The term was used in the past to describe disparity in actual and measured plasma/ capillary glucose.
The term clinical pseudohypoglycemia is used when patients with personality and psychological disorders report relief of symptoms (eg, mental dullness, disorientation, confusion, palpitations) after eating. Plasma glucose levels are within reference ranges in all such patients while they are symptomatic.[3, 4]
It is important for clinicians to recognize the difference between true and pseudohypoglycemia to prevent unnecessary investigations or treatment for the same.
Pseudohypoglycemia or artifactual hypoglycemia can occur in the following situations:
Severe acidosis (pH <6.95) can falsely decrease glucose readings[22]
Patients receiving high flow oxygen can have false low readings with glucose meter using glucose oxidase method[22]
High hematocrit as in neonates can also cause false low blood glucose readings.[25]
Venous plasma glucose concentration greater than 70 mg/dL (3.9 mmol/L) after an overnight fast are within reference ranges. As per ADA guidelines, hypoglycemia is considered if plasma glucose is less than 70 mg/dL (3.9 mmol/L).[26] However, in some groups of patients, like young females, values of 50-70 mg/dL (2.8-3.9 mmol/L) may be normal.[27]
Plasma insulin levels and levels of compensatory counterregulatory hormones, such as glucagon, cortisol, growth hormone, and catecholamines, are within reference ranges when pseudohypoglycemia is found.
Evaluating concurrent blood count as well as other parameters like protein is important to evaluate the cause for falsely low glucose levels.
Since the discovery of insulin in 1924, hypoglycemic symptoms have been reported in nondiabetic patients. It was thought to result from dysinsulinism.[28] In 1975, Yager and Young described a syndrome of nonhypoglycemia in which patients presented with varied spectrum of symptoms that they attributed to low glucose.[29]
In 1961, Field et al used the term artifactual hypoglycemia to describe the falsely low glucose that occurred in patients with chronic myelogenous leukemia.[30]
The terms pseudohypoglycemia and artifactual hypoglycemia have been used since then to describe the symptomatology.
The patients may be asymptomatic and they may be subjected to unnecessary testing based on the abnormal laboratory result. Occasionally, patients may present with nonspecific symptoms such as fatigue, headache, visual disturbances, and lightheadedness.
Clinical correlation becomes of utmost importance in such circumstances. Some patients may present with typical symptoms of neuroglycopenia like slurred speech, confusion, and, rarely, seizures and coma, in which case further workup is required.
The clinical diagnosis of hypoglycemia is established when symptoms are consistent with hypoglycemia, a low plasma glucose concentration is confirmed, and symptoms subside in the presence of normal plasma glucose levels (Whipple's triad).
Absence of symptoms with low glucose values should raise the suspicion of artifactual hypoglycemia. The following actions are recommended in an effort to prevent it: